Blood disorder

Favism (G6PD deficiency): what should you avoid?

Fava beans, certain medicines and naphthalene; the signs of an attack and what to do, newborn jaundice and screening, and living a normal life with G6PD deficiency

Updated: 29 October 202610 min read15 references
Show content for:
Short answer

G6PD enzyme deficiency, often called "favism", is an inherited trait of red blood cells, and most people who have it never have symptoms [1]. The danger comes when red blood cells meet a "trigger" and are suddenly destroyed: eating fava beans, certain medicines, naphthalene (mothballs) and infections [1, 2, 6]. If after any of these your urine turns dark, your eyes turn yellow, or you become pale and very tired, see a doctor or go to an emergency department the same day [8, 9].

Key points

  • G6PD deficiency is inherited and common in some regions: in a large analysis from Iran, about 1 in 15 people had it, and it was about 4 times as common in men as in women [3].
  • Most people with it live completely normal lives and never have symptoms; problems arise only when they meet a "trigger" [1].
  • The main triggers are fava beans, certain medicines, naphthalene and infections [1, 2, 6]. In a study from Iran, almost 9 in 10 people admitted to hospital with a haemolytic attack had eaten fava beans [4].
  • Signs of an attack: dark urine, yellow eyes and skin, pale skin and tiredness; if recognised early, it is treated well [1, 8, 9].
  • Babies with the deficiency can develop severe jaundice that needs prompt treatment; newborn screening and follow-up help prevent brain damage [7].
  • Tell every doctor, dentist and pharmacist you see that you have G6PD deficiency [2, 13].

What is favism?

Red blood cells need an enzyme called G6PD to protect themselves against "oxidative" damage (a kind of chemical damage) [2]. In G6PD deficiency this enzyme is low, so when the body meets certain foods, medicines, chemicals or infections, red blood cells can suddenly be destroyed. This destruction is called "haemolysis", and the anaemia it causes is called "haemolytic anaemia" [2].

The word "favism" originally means a haemolytic attack after eating fava beans [2], but it is often used for G6PD deficiency itself. The condition is inherited; it is neither cancer nor contagious [1]. Around 500 million people worldwide have G6PD deficiency, and most of them never have symptoms in their lifetime [1].

Why is it more common in men? The G6PD gene is on the X chromosome [2]. Men have only one X chromosome, so if that single copy is faulty, they have the deficiency. Women have two X chromosomes and most are "carriers"; but the amount of enzyme in carrier women varies from normal to very low, and some of them can also have haemolysis just like men [2].

How common is it? It is common in many countries; in Iran, an analysis that combined 36 studies of nearly 150,000 people found that about 1 in 15 people had G6PD deficiency: about 1 in 11 men and about 1 in 45 women [3]. How common it was varied widely between regions of that country, from fewer than 1 to about 15 in every 100 people [3].

Get to know other common types of anaemia too: thalassaemia minor, iron-deficiency anaemia and vitamin B12 deficiency.

What should you avoid?

The key to living well with G6PD deficiency is avoiding triggers; this is the most effective way to prevent haemolysis [14]. These are the most important ones:

Fava beans

Fava beans (broad beans) and foods that contain them were the main trigger of attacks in a study from Iran [4]. In a review of the studies, fava beans were the only food with conclusive evidence of causing haemolysis in G6PD deficiency [5].

Certain medicines

The most important are the antimalarial medicines primaquine and tafenoquine, dapsone (used for some skin diseases and leprosy), methylene blue (a blue medicine and dye used in hospitals), rasburicase (used to lower uric acid during treatment of some cancers) and pegloticase (for gout that does not respond to other treatment) [2]. The urinary antibiotic nitrofurantoin should be used only with caution [2].

Naphthalene (mothballs)

In one study, more than half of the children with G6PD deficiency admitted to hospital with haemolysis had been exposed to naphthalene, and most of them needed a blood transfusion [6]. A newborn baby also developed severe jaundice just from contact with clothes treated with naphthalene or from its fumes [7]. Do not keep naphthalene at home, and do not store clothes, especially baby clothes, with it [6, 7].

Infections

Infections can also start a haemolytic attack [1, 2]. In a study from Iran, about 1 in 10 attacks was due to an infection [4]. If you have a fever or an infection and your urine turns dark, see a doctor promptly.

For patients

What about other foods? Some lists ban other foods as well. But a review of the studies found conclusive evidence for no food other than fava beans, and food additives, at the levels permitted in North America, were safe for most people with the deficiency [5]. An expert guideline also found no reliable evidence of risk from other foods [2].

What about other medicines? Many common medicines, at usual doses, carry no added risk for people with G6PD deficiency [2]. But do not decide the list yourself: before taking any medicine, even one bought without a prescription, tell your doctor and pharmacist that you have G6PD deficiency [2].

During breastfeeding: a few cases have been reported in which a breastfed baby with G6PD deficiency developed haemolysis after the mother ate fava beans [7]. If your baby has G6PD deficiency, talk to your baby's doctor about eating fava beans while breastfeeding. The medicine tafenoquine must not be used while breastfeeding a baby who has G6PD deficiency or whose status is unknown [9].

For physiciansRisk of acute haemolysis with medicines in G6PD deficiency (CPIC guideline, 2023) · Rasburicase.
For physicians
Risk of acute haemolysis with medicines in G6PD deficiency (CPIC guideline, 2023)
Risk levelDrugsRecommendation
High riskDapsone, methylene blue, pegloticase, primaquine at standard or higher dose (0.25 to 0.5 mg/kg daily for 14 days), rasburicase, tafenoquine, toluidine blueAvoid [2]
Medium riskNitrofurantoin; primaquine at medium dose (0.75 mg/kg or 45 mg once weekly for 8 weeks) for vivax malariaStandard dose with caution and close monitoring for anaemia [2]
Low to no risk4-aminosalicylic acid, aspirin up to 1 g a day, chloramphenicol, chloroquine, ciprofloxacin, dimercaprol, doxorubicin, furazolidone, glibenclamide (glyburide), hydroxychloroquine, mafenide, nalidixic acid, norfloxacin, ofloxacin, phenazopyridine, primaquine single dose 0.25 mg/kg for falciparum malaria, quinine, sulfadiazine, sulfadimidine, sulfamethoxazole, sulfanilamide, sulfasalazine, sulfafurazole (sulfisoxazole), tolbutamide, vitamin C, vitamin KStandard doses regardless of G6PD status; closer monitoring at higher than usual doses, with infection or with several drugs together [2]
No recommendation (insufficient evidence)Aspirin above 1 g a day, chlorpropamide, dabrafenib, gliclazide, glimepiride, glipizide, mepacrine, mesalazine, moxifloxacin, nicorandil, nitrofural, probenecid, sodium nitrite, sulfacetamide, tolazamide, trametinibNo recommendation made [2]

In G6PD deficiency with chronic non-spherocytic haemolytic anaemia (CNSHA), avoid high-‎ and medium-risk drugs and use all drugs with caution and monitoring. The risk of haemolysis increases with dose [2].

For physicians

Rasburicase. Contraindicated in G6PD deficiency (haemolysis and methaemoglobinaemia); before starting, screen patients at higher risk (for example, of African or Mediterranean ancestry), and if haemolysis occurs, stop the drug immediately and permanently [10]. CPIC: when tumour lysis is anticipated and G6PD status is not available in time, or leucocytosis and anaemia confound the enzyme activity result, weigh the risk of haemolysis and methaemoglobinaemia against the complications of tumour lysis syndrome; allopurinol may not lower uric acid as effectively as rasburicase [2]. Tool: tumour lysis syndrome criteria; lesson: oncological emergencies.

Primaquine. In G6PD deficiency, avoid the standard anti-relapse dose (0.25 to 0.5 mg/kg daily for 14 days). For radical cure of the liver stage of vivax or ovale malaria: 0.75 mg/kg once weekly for 8 weeks (WHO) or 45 mg once weekly for 8 weeks (CDC), with close monitoring for haemolysis; a single dose of 0.25 mg/kg as a gametocytocide in falciparum malaria, without the need for haemolysis monitoring; in CNSHA, no dose is safe [2].

Tafenoquine. G6PD testing is mandatory before prescribing; it is contraindicated in G6PD deficiency or unknown G6PD status, and enzyme activity below 70% of normal was an exclusion criterion in the trials [9]; CPIC also regards its safety as established only for activity of 70% or more [2]. Not recommended in pregnancy (risk of haemolysis in a G6PD-deficient fetus) and contraindicated while breastfeeding an infant who is G6PD deficient or of unknown status [9].

Methylene blue and dapsone are high-risk drugs [2]. Methaemoglobinaemia may accompany anaemia in G6PD deficiency [2].

Food and breastfeeding. In a review of the studies, fava beans were the only food with conclusive clinical evidence of haemolysis, and food additives at the levels permitted in North America were safe for most patients [5]; CPIC also found no peer-reviewed evidence of risk from other foods [2]. Haemolysis has been reported in breastfed infants with the deficiency after the mother ate fava beans [7].

Symptoms of an attack and its treatment

A haemolytic attack usually starts after a trigger, such as eating fava beans, a particular medicine or an infection [1]. Know these signs [8, 9]:

  • Dark urine (dark red or brown)
  • Yellowing of the whites of the eyes or of the skin
  • Pale skin, tiredness and feeling unwell
  • Dizziness, light-headedness, confusion or shortness of breath
  • Darkening of the lips

Most attacks are treated well if they are recognised early [1]. In hospital, the doctor checks how severe the anaemia is with blood tests, gives fluids through a drip and, if the anaemia is severe, a blood transfusion [8]. In a study of 308 children with favism attacks in Iran, most attacks were caused by eating fava beans, most children were treated with fluids, and about 1 in 3 needed a blood transfusion [8].

The enzyme deficiency itself is inherited and lifelong; there is still no medicine that treats it [15]. That is why the most important thing after any attack is to identify the trigger and avoid it, so that the attack does not happen again [14].

For physiciansClinical data.
For physicians

Clinical data. In 308 children with haemolysis due to G6PD deficiency in Lorestan, Iran, the most common complaint was jaundice (82.5%) and the most common cause fava beans (85.7%); 68% received hydration and 36.36% a blood transfusion (mean 18.9 mL/kg); the authors attributed more transfusions and longer hospital stays to incorrect calculation of the volume of blood needed [8]. In Fars, Iran, the causes of haemolysis in 850 registered patients were fava beans 88.2%, underlying infection 10.9% and drugs 0.8% [4]. Naphthalene: of 24 children admitted with acute haemolysis and G6PD deficiency, 14 (58.3%) had been exposed to naphthalene; 79% of them needed a transfusion, compared with 60% of the infection-associated haemolysis group [6]. In G6PD deficiency, methaemoglobinaemia may accompany haemolysis, and methylene blue is a high-risk drug [2].

Newborn jaundice and screening

G6PD deficiency increases a newborn baby's risk of severe jaundice. This jaundice can rise quickly and, if not treated in time, can cause permanent brain damage (kernicterus) [7]. Newborn jaundice is treated with light therapy (phototherapy), and an exchange transfusion is sometimes needed [7, 13].

In a review from Iran of babies admitted to hospital with jaundice, about 1 in 14 had G6PD deficiency, about 4 times as often in boys as in girls [12].

Newborn screening. The World Health Organization recommends testing all newborn babies in countries where this deficiency is common [7]. Some of these countries, such as Iran, have introduced newborn screening programmes for G6PD deficiency [4, 11]. In one Iranian province, hospital admissions for haemolytic attacks fell by almost half after newborn screening started [4].

But the simple screening test does not find everyone with the deficiency, especially girls [7, 11]. So if your baby's screening result was normal but signs of haemolysis appear later, or there is G6PD deficiency in your family, tell your doctor so that a more accurate test that measures the amount of enzyme can be done [2, 11].

If your baby has G6PD deficiency, take their jaundice seriously and do not store their clothes with naphthalene [7].

Which tests?

For patients

G6PD deficiency is diagnosed with a blood test that measures the activity of the G6PD enzyme in red blood cells [2]. Simple (qualitative) tests only show whether the enzyme is very low or not; "quantitative" tests measure the amount of enzyme and are more accurate for women and for people with moderate deficiency [7, 11].

Timing matters. During a haemolytic attack or shortly after it, and after a blood transfusion, the result can wrongly come back as normal, because younger red cells and donated blood contain more enzyme [2]. If you were tested at such a time, do not take a normal result as final; talk to your doctor about repeating it [2].

In women, the amount of enzyme can be normal, slightly low or very low; this is why women need a quantitative test, and a genetic test alone is not enough [2]. To read a blood count report: understanding your CBC results.

For physiciansDiagnostic pitfalls (CPIC 2023).
For physicians

Diagnostic pitfalls (CPIC 2023). Most diagnoses rely on measuring enzyme activity in whole blood. Recent haemolysis (higher G6PD activity in reticulocytes and young red cells) or a recent transfusion can bring activity in a deficient person into the normal range; newborns have higher activity than older children and adults; activity correlates positively with leucocyte and platelet counts and may be unreliable in anaemia or acute leukaemia [2]. In heterozygous people (usually women), mosaicism from random X inactivation means that genotype does not predict phenotype and activity must be measured; they can have drug-induced haemolysis similar to homozygotes [2]. Genotyping panels cover only the more common alleles, and a negative result does not exclude deficiency [2].

Newborn screening data from Iran. In 365 newborns with Mazandarani parents, the fluorescent spot test (FST) identified only 13 affected boys and no girls; a quantitative assay showed deficiency in 19 boys and 28 girls, and DNA analysis 14 hemizygous boys and 34 heterozygous girls; the authors recommend the quantitative assay as the preferred method [11]. FST detects only activity of 20% or less of the normal mean [7]. In Fars, 553 admissions were recorded before newborn screening (2001 to 2004) and 297 after it (2005 to 2008); 237 of the admissions in the second period had been classified as "normal" at screening [4]. Prevalence of G6PD deficiency in newborns admitted with jaundice in Iran: 7.0% (95% CI 5.5 to 8.5; boys 12.1%, girls 3.0%) [12]. Overall prevalence in Iran 6.7% (men 8.8%, women 2.2%; 36 studies, 148,916 people) [3].

Classification. The new WHO classification proposed in 2022: A (activity below 20%, chronic haemolysis), B (below 45%, acute triggered haemolysis), C (60 to 150%, no haemolysis) and U (any activity, uncertain clinical significance) [2].

Daily life with favism

  1. 1

    Avoid triggers

    Do not eat fava beans, do not keep naphthalene at home, and ask before taking any medicine [2, 6].

  2. 2

    Tell everyone

    Tell every doctor, dentist, midwife and pharmacist you see that you have G6PD deficiency. Education and information prevent most complications of this deficiency [13].

  3. 3

    Take infections seriously

    An infection can start an attack; when you have a fever or an infection, watch for dark urine and jaundice [1, 2].

  4. 4

    Think about your family

    Because the condition is inherited, other family members may have it too; a blood test can show their status [1, 2].

  5. 5

    The rest of life is normal

    Most people with G6PD deficiency never have symptoms and live normal lives [1].

When should I see a doctor urgently?

Call your local emergency number or go to an emergency department straight away if [8, 9]:

  • you have dark urine with severe pallor, feeling very unwell or shortness of breath
  • you are confused or your lips have turned dark

See a doctor the same day if your urine has turned dark, your eyes or skin have turned yellow, or you have become pale and tired after eating fava beans, taking a medicine or being exposed to naphthalene [8, 9].

Babies: if your baby is yellow and the jaundice is getting worse, take them to a doctor the same day; jaundice in a baby with G6PD deficiency can rise quickly [7].

If you are not sure whether a medicine you have been prescribed is safe for you, ask your doctor or pharmacist before taking it [2].

Frequently asked questions

What should people with favism not eat?

The most important are fava beans and foods containing them [2, 5]. For other foods, a review of the studies found no conclusive evidence [5]. Also do not take medicines without checking with a doctor or pharmacist [2].

Can favism be cured?

The enzyme deficiency is inherited and lifelong; there is still no medicine that treats the deficiency itself [15]. The most effective approach is to prevent attacks by avoiding triggers [14], and if an attack does happen, it is controlled with prompt diagnosis and treatment [1].

Can women have favism?

Yes, but less often than men [3]. Women who carry one faulty copy of the gene can have normal or low enzyme levels, and some of them have haemolysis just like men [2]. So if you are a carrier, find out your enzyme level with a quantitative test and talk to your doctor about triggers [2].

Can people with G6PD deficiency take aspirin, ciprofloxacin or co-trimoxazole?

An expert guideline classes aspirin up to 1 g a day, ciprofloxacin, sulfamethoxazole (one of the two medicines in co-trimoxazole), vitamin C and vitamin K at usual doses as low risk [2]. But at higher than usual doses or with an infection, closer monitoring is needed, so always tell your doctor that you have G6PD deficiency [2].

Is favism inherited? Will my children have it?

Yes, it is inherited, and the gene is on the X chromosome [1, 2]. Boys get their X chromosome from their mother, so a carrier mother can pass it on to her sons. If someone in your family has G6PD deficiency, talk to your doctor about testing other family members [2].

What is the G6PD test and when is it done?

It is a blood test that measures the enzyme's activity [2]. It is done in newborn babies as screening [7]; it is required before taking tafenoquine [9], and before rasburicase in people more likely to have G6PD deficiency [10]. If the test is done during an attack or shortly after a blood transfusion, it can wrongly come back as normal [2].

Related links

References

15 references
Show all referencesClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Glucose-6-phosphate dehydrogenase deficiencyLuzzatto L, Ally M, Notaro R · Blood · 2020;136:1225-1240
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
  2. 2
    Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeGammal RS, Pirmohamed M, Somogyi AA, et al · Clin Pharmacol Ther · 2023;113:973-985
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
  3. 3
    Prevalence of G6PD deficiency in Iran, a mata-analysisMoosazadeh M, Amiresmaili M, Aliramezany M · Acta Med Iran · 2014;52:256-64
    PubMed Back to text: 1 2 3 4 5
  4. 4
    The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern IranCohan N, Karimi M, Khalili AH, et al · J Med Screen · 2010;17:66-7
    DOIPubMed Back to text: 1 2 3 4 5 6 7
  5. 5
    Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiencyLa Vieille S, Lefebvre DE, Khalid AF, et al · Nutr Rev · 2019;77:96-106
    DOIPubMed Back to text: 1 2 3 4 5
  6. 6
    Association of naphthalene with acute hemolytic anemiaSantucci K, Shah B · Acad Emerg Med · 2000;7:42-7
    DOIPubMed Back to text: 1 2 3 4 5 6
  7. 7
    Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease HeterogeneityLee HY, Ithnin A, Azma RZ, et al · Front Pediatr · 2022;10:875877
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
  8. 8
    Clinical Manifestations and Therapeutic Findings of the Children with Glucose-6-Phosphate Dehydrogenase Deficiency Presenting FavismTarhani F, Nezami A, Heidari G, et al · Endocr Metab Immune Disord Drug Targets · 2021;21:1125-1129
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8
  9. 9
    KRINTAFEL (tafenoquine) tablets, for oral use: Prescribing InformationGlaxoSmithKline LLC · DailyMed, U.S. National Library of Medicine · 2026
    Source Back to text: 1 2 3 4 5 6 7 8 9
  10. 10
    ELITEK (rasburicase) for injection, for intravenous use: Prescribing InformationSanofi-Aventis U.S. LLC · DailyMed, U.S. National Library of Medicine · 2026
    Source Back to text: 1 2
  11. 11
    Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?Kosaryan M, Mahdavi MR, Jalali H, et al · Pediatr Hematol Oncol · 2014;31:95-100
    DOIPubMed Back to text: 1 2 3 4 5
  12. 12
    Prevalence of G6PD deficiency in Iranian neonates with jaundice: a systematic review and meta-analysisJavadi M, Deravi S, Zarei S, et al · J Matern Fetal Neonatal Med · 2022;35:5813-5820
    DOIPubMed Back to text: 1 2
  13. 13
    Glucose-6-phosphate dehydrogenase deficiency. WHO Working GroupBull World Health Organ · 1989;67:601-11
    PubMed Back to text: 1 2 3
  14. 14
    Glucose-6-phosphate dehydrogenase deficiencyCappellini MD, Fiorelli G · Lancet · 2008;371:64-74
    DOIPubMed Back to text: 1 2 3
  15. 15
    Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectivesGarcia AA, Koperniku A, Ferreira JCB, et al · Trends Pharmacol Sci · 2021;42:829-844
    DOIPubMed Back to text: 1 2

This page is based on reputable scientific sources and was last updated on 29 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.